Source: Laboratory investigation. Conference titles: Annual Meeting of the United States and Canadian Academy of Pathology. Unidade: FM
Subjects: NEOPLASIAS PROSTÁTICAS, EXPRESSÃO GÊNICA, PROSTÁTA (CIRURGIA), RESUMOS (EVENTOS)
ABNT
MOURA, Caio M. et al. Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf. Acesso em: 14 nov. 2024. , 2016APA
Moura, C. M., Reis, S. T., Pontes, J., Viana, N., Dip, N., Srougi, M., & Leite, K. R. M. (2016). Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdfNLM
Moura CM, Reis ST, Pontes J, Viana N, Dip N, Srougi M, Leite KRM. Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer [Internet]. Laboratory investigation. 2016 ; 96 250A-251A.[citado 2024 nov. 14 ] Available from: http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdfVancouver
Moura CM, Reis ST, Pontes J, Viana N, Dip N, Srougi M, Leite KRM. Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer [Internet]. Laboratory investigation. 2016 ; 96 250A-251A.[citado 2024 nov. 14 ] Available from: http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf